Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues

Carolina Boni, Diletta Laccabue, Pietro Lampertico, Tiziana Giuberti, Mauro Viganò, Simona Schivazappa, Arianna Alfieri, Marco Pesci, Giovanni B. Gaeta, Giuseppina Brancaccio, Massimo Colombo, Gabriele Missale, Carlo Ferrari

Research output: Contribution to journalArticle

Abstract

BACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) infection, persistent exposure to high concentrations of antigen can disrupt T-cell functions. It is not clear to what extent long-term suppression of HBV by nucleos(t)ide analogues can restore antiviral T-cell functions. We compared HBV-specific T-cell responses of patients treated with nucleos(t)ide analogues with those detected in other conditions of HBV control. METHODS: We analyzed intracellular levels of interferon gamma, interleukin-2, and tumor necrosis factor α in HBV-specific T cells after 10 days of stimulation with peptides covering the overall HBV genotype D sequence and ex vivo with selected CD8 epitopes and the corresponding HLA-A2 dextramers. Findings from patients treated with nucleos(t)ide analogues who had complete (HBV DNA negative/antibody to hepatitis B surface antigen positive) or partial (HBV DNA negative/hepatitis B surface antigen positive) control of their infections were compared with those of patients with spontaneous or interferon alfa-induced resolution of acute or chronic infections, inactive HBV carriers, or untreated hepatitis B e antigen-negative patients with chronic infections. RESULTS: Although HBV-specific T cells from nucleos(t)ide analogue-treated patients with complete control of infection were dysfunctional ex vivo, they had efficient responses after in vitro expansion. These responses were comparable to those of patients who spontaneously resolved acute HBV infection. Nucleos(t)ide analogue-treated patients who were HBV DNA negative but hepatitis B surface antigen positive had lower levels of T-cell responses but responses greater than those of untreated patients with chronic infection. CONCLUSIONS: In vitro reactivity can be restored to T cells from patients with suppressed HBV infection following long-term treatment with nucleos(t)ide analogues, despite prolonged exposure to large loads of antigen. Immune therapies that increase the antiviral T-cell response might increase the likelihood of complete HBV control in patients undergoing long-term nucleos(t)ide analogue treatment.

Original languageEnglish
JournalGastroenterology
Volume143
Issue number4
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Hepatitis B virus
T-Lymphocytes
Therapeutics
Virus Diseases
Hepatitis B Surface Antigens
Infection Control
Antiviral Agents
DNA
Infection
HLA-A2 Antigen
Antigens
Hepatitis B e Antigens
Chronic Hepatitis B
Interferon-alpha
Interferon-gamma
Interleukin-2
Epitopes
Tumor Necrosis Factor-alpha
Genotype

Keywords

  • Cytokines
  • HBeAg
  • HBsAg
  • IFN-γ

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. / Boni, Carolina; Laccabue, Diletta; Lampertico, Pietro; Giuberti, Tiziana; Viganò, Mauro; Schivazappa, Simona; Alfieri, Arianna; Pesci, Marco; Gaeta, Giovanni B.; Brancaccio, Giuseppina; Colombo, Massimo; Missale, Gabriele; Ferrari, Carlo.

In: Gastroenterology, Vol. 143, No. 4, 10.2012.

Research output: Contribution to journalArticle

Boni, C, Laccabue, D, Lampertico, P, Giuberti, T, Viganò, M, Schivazappa, S, Alfieri, A, Pesci, M, Gaeta, GB, Brancaccio, G, Colombo, M, Missale, G & Ferrari, C 2012, 'Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues', Gastroenterology, vol. 143, no. 4. https://doi.org/10.1053/j.gastro.2012.07.014
Boni, Carolina ; Laccabue, Diletta ; Lampertico, Pietro ; Giuberti, Tiziana ; Viganò, Mauro ; Schivazappa, Simona ; Alfieri, Arianna ; Pesci, Marco ; Gaeta, Giovanni B. ; Brancaccio, Giuseppina ; Colombo, Massimo ; Missale, Gabriele ; Ferrari, Carlo. / Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. In: Gastroenterology. 2012 ; Vol. 143, No. 4.
@article{aedbb20aafe64c5ba9d23ce3df2bf474,
title = "Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues",
abstract = "BACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) infection, persistent exposure to high concentrations of antigen can disrupt T-cell functions. It is not clear to what extent long-term suppression of HBV by nucleos(t)ide analogues can restore antiviral T-cell functions. We compared HBV-specific T-cell responses of patients treated with nucleos(t)ide analogues with those detected in other conditions of HBV control. METHODS: We analyzed intracellular levels of interferon gamma, interleukin-2, and tumor necrosis factor α in HBV-specific T cells after 10 days of stimulation with peptides covering the overall HBV genotype D sequence and ex vivo with selected CD8 epitopes and the corresponding HLA-A2 dextramers. Findings from patients treated with nucleos(t)ide analogues who had complete (HBV DNA negative/antibody to hepatitis B surface antigen positive) or partial (HBV DNA negative/hepatitis B surface antigen positive) control of their infections were compared with those of patients with spontaneous or interferon alfa-induced resolution of acute or chronic infections, inactive HBV carriers, or untreated hepatitis B e antigen-negative patients with chronic infections. RESULTS: Although HBV-specific T cells from nucleos(t)ide analogue-treated patients with complete control of infection were dysfunctional ex vivo, they had efficient responses after in vitro expansion. These responses were comparable to those of patients who spontaneously resolved acute HBV infection. Nucleos(t)ide analogue-treated patients who were HBV DNA negative but hepatitis B surface antigen positive had lower levels of T-cell responses but responses greater than those of untreated patients with chronic infection. CONCLUSIONS: In vitro reactivity can be restored to T cells from patients with suppressed HBV infection following long-term treatment with nucleos(t)ide analogues, despite prolonged exposure to large loads of antigen. Immune therapies that increase the antiviral T-cell response might increase the likelihood of complete HBV control in patients undergoing long-term nucleos(t)ide analogue treatment.",
keywords = "Cytokines, HBeAg, HBsAg, IFN-γ",
author = "Carolina Boni and Diletta Laccabue and Pietro Lampertico and Tiziana Giuberti and Mauro Vigan{\`o} and Simona Schivazappa and Arianna Alfieri and Marco Pesci and Gaeta, {Giovanni B.} and Giuseppina Brancaccio and Massimo Colombo and Gabriele Missale and Carlo Ferrari",
year = "2012",
month = "10",
doi = "10.1053/j.gastro.2012.07.014",
language = "English",
volume = "143",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues

AU - Boni, Carolina

AU - Laccabue, Diletta

AU - Lampertico, Pietro

AU - Giuberti, Tiziana

AU - Viganò, Mauro

AU - Schivazappa, Simona

AU - Alfieri, Arianna

AU - Pesci, Marco

AU - Gaeta, Giovanni B.

AU - Brancaccio, Giuseppina

AU - Colombo, Massimo

AU - Missale, Gabriele

AU - Ferrari, Carlo

PY - 2012/10

Y1 - 2012/10

N2 - BACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) infection, persistent exposure to high concentrations of antigen can disrupt T-cell functions. It is not clear to what extent long-term suppression of HBV by nucleos(t)ide analogues can restore antiviral T-cell functions. We compared HBV-specific T-cell responses of patients treated with nucleos(t)ide analogues with those detected in other conditions of HBV control. METHODS: We analyzed intracellular levels of interferon gamma, interleukin-2, and tumor necrosis factor α in HBV-specific T cells after 10 days of stimulation with peptides covering the overall HBV genotype D sequence and ex vivo with selected CD8 epitopes and the corresponding HLA-A2 dextramers. Findings from patients treated with nucleos(t)ide analogues who had complete (HBV DNA negative/antibody to hepatitis B surface antigen positive) or partial (HBV DNA negative/hepatitis B surface antigen positive) control of their infections were compared with those of patients with spontaneous or interferon alfa-induced resolution of acute or chronic infections, inactive HBV carriers, or untreated hepatitis B e antigen-negative patients with chronic infections. RESULTS: Although HBV-specific T cells from nucleos(t)ide analogue-treated patients with complete control of infection were dysfunctional ex vivo, they had efficient responses after in vitro expansion. These responses were comparable to those of patients who spontaneously resolved acute HBV infection. Nucleos(t)ide analogue-treated patients who were HBV DNA negative but hepatitis B surface antigen positive had lower levels of T-cell responses but responses greater than those of untreated patients with chronic infection. CONCLUSIONS: In vitro reactivity can be restored to T cells from patients with suppressed HBV infection following long-term treatment with nucleos(t)ide analogues, despite prolonged exposure to large loads of antigen. Immune therapies that increase the antiviral T-cell response might increase the likelihood of complete HBV control in patients undergoing long-term nucleos(t)ide analogue treatment.

AB - BACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) infection, persistent exposure to high concentrations of antigen can disrupt T-cell functions. It is not clear to what extent long-term suppression of HBV by nucleos(t)ide analogues can restore antiviral T-cell functions. We compared HBV-specific T-cell responses of patients treated with nucleos(t)ide analogues with those detected in other conditions of HBV control. METHODS: We analyzed intracellular levels of interferon gamma, interleukin-2, and tumor necrosis factor α in HBV-specific T cells after 10 days of stimulation with peptides covering the overall HBV genotype D sequence and ex vivo with selected CD8 epitopes and the corresponding HLA-A2 dextramers. Findings from patients treated with nucleos(t)ide analogues who had complete (HBV DNA negative/antibody to hepatitis B surface antigen positive) or partial (HBV DNA negative/hepatitis B surface antigen positive) control of their infections were compared with those of patients with spontaneous or interferon alfa-induced resolution of acute or chronic infections, inactive HBV carriers, or untreated hepatitis B e antigen-negative patients with chronic infections. RESULTS: Although HBV-specific T cells from nucleos(t)ide analogue-treated patients with complete control of infection were dysfunctional ex vivo, they had efficient responses after in vitro expansion. These responses were comparable to those of patients who spontaneously resolved acute HBV infection. Nucleos(t)ide analogue-treated patients who were HBV DNA negative but hepatitis B surface antigen positive had lower levels of T-cell responses but responses greater than those of untreated patients with chronic infection. CONCLUSIONS: In vitro reactivity can be restored to T cells from patients with suppressed HBV infection following long-term treatment with nucleos(t)ide analogues, despite prolonged exposure to large loads of antigen. Immune therapies that increase the antiviral T-cell response might increase the likelihood of complete HBV control in patients undergoing long-term nucleos(t)ide analogue treatment.

KW - Cytokines

KW - HBeAg

KW - HBsAg

KW - IFN-γ

UR - http://www.scopus.com/inward/record.url?scp=84866705034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866705034&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2012.07.014

DO - 10.1053/j.gastro.2012.07.014

M3 - Article

C2 - 22796241

AN - SCOPUS:84866705034

VL - 143

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -